News
StockStory.org on MSN2d
Saia (NASDAQ:SAIA) Surprises With Q2 Sales, Stock Jumps 12.6%Freight transportation and logistics provider Saia (NASDAQ:SAIA) in Q2 CY2025, but sales were flat year on year at $817.1 ...
Stocks That Just Made Investors Richer. Nasdaq, Inc. (NASDAQ:NDAQ) is one of the best-performing stocks on Thursday. Nasdaq ...
StockStory.org on MSN2d
First Citizens BancShares’s (NASDAQ:FCNCA) Q2: Beats On RevenueRegional banking company First Citizens BancShares (NASDAQGS:FCNC.A) announced in Q2 CY2025, but sales fell by 3.5% year on ...
Sold 36,032 shares of PepsiCo in Q2; transaction value as of June 30, 2025: $4.76 million. Represented 2.61% of 13F reportable assets under management in Q2 2025. Post-trade stake: zero shares, valued ...
Palantir's expansion into commercial markets has boosted its business. The stock has been on a tear since the start of 2024. Palantir's valuation is sky-high.
Insiders sold stocks in Q2, which could present a headwind for some markets in Q3. However, in most cases, the selling aligns with trends, revealing that share-based compensation is in play and ...
Q2 review: Market maturation ... Reports of Circle (NYSE:CRCL), BitGo, Coinbase Global (NASDAQ:COIN) and Paxos exploring bank charters further underscored the convergence of TradFi and DeFi, ...
Reporting Q2 EPS of $2.10, Delta was able to exceed expectations of $2.04 by nearly 3% despite a decline from earnings of $2.36 a share in a tough-to-compete-against prior year quarter.
ImmuCell plans to host a conference call on August 15, 2025, at 9:00 AM ET to discuss Q2 2025 results. Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire.
JPM reports Q2 earnings next week. Will rising NII and markets revenues likely offset weaker IB income? Let's find out and see whether to buy now or wait.
Earnings Surprise History Image Source: Zacks Investment Research Factors to Influence Citigroup’s Q2 Results. NII: In the second quarter, the Federal Reserve kept interest rates unchanged at 4. ...
Evolent is reiterating its Q2 2025 Adjusted EBITDA guidance of $ ... views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results